R T Calado1, J A Regal, S Kajigaya, N S Young. 1. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA. calador@mail.nih.gov
Abstract
BACKGROUND: Loss-of-function mutations in telomerase complex genes reduce telomerase activity and shorten overall telomere length in leucocytes, and they can clinically manifest as bone marrow failure (aplastic anaemia and dyskeratosis congenita) and familial pulmonary fibrosis. Telomeres are constituted of double-stranded tandem TTAGGG repeats followed by a 3' G-rich single-stranded overhang, a crucial telomeric structural component responsible for the t-loop formation. MATERIALS AND METHODS: We investigated the length of telomeric overhangs in 25 healthy individuals from 0 to 76 years of age, 16 patients with aplastic anaemia, and 13 immediate relatives using a non-denaturing in-gel method and the telomere-oligonucleotide ligation assay. RESULTS: Telomeric overhang lengths were constant from birth to eighth decade of life in healthy subjects, in contrast to overall telomere length, which shortened with ageing. Most patients with marrow failure and a telomerase gene mutation showed marked erosion of telomeric overhang associated with critically short telomeres; in other aplastic patients with normal genotypes, normal overall telomere lengths and who responded to immunosuppressive therapy, telomeric overhangs were maintained. CONCLUSIONS: Telomeric overhang erosion does not participate in physiological ageing but support a role for eroded telomeric overhangs and abnormal telomere structure in pathological shortening of telomeres, especially caused by loss-of-function telomerase mutations. Disrupted telomere structure caused by short telomeric overhangs may contribute to the mechanisms of abnormal haematopoietic compartment senescence and chromosomal instability in human bone marrow failure.
BACKGROUND: Loss-of-function mutations in telomerase complex genes reduce telomerase activity and shorten overall telomere length in leucocytes, and they can clinically manifest as bone marrow failure (aplastic anaemia and dyskeratosis congenita) and familial pulmonary fibrosis. Telomeres are constituted of double-stranded tandem TTAGGG repeats followed by a 3' G-rich single-stranded overhang, a crucial telomeric structural component responsible for the t-loop formation. MATERIALS AND METHODS: We investigated the length of telomeric overhangs in 25 healthy individuals from 0 to 76 years of age, 16 patients with aplastic anaemia, and 13 immediate relatives using a non-denaturing in-gel method and the telomere-oligonucleotide ligation assay. RESULTS: Telomeric overhang lengths were constant from birth to eighth decade of life in healthy subjects, in contrast to overall telomere length, which shortened with ageing. Most patients with marrow failure and a telomerase gene mutation showed marked erosion of telomeric overhang associated with critically short telomeres; in other aplasticpatients with normal genotypes, normal overall telomere lengths and who responded to immunosuppressive therapy, telomeric overhangs were maintained. CONCLUSIONS: Telomeric overhang erosion does not participate in physiological ageing but support a role for eroded telomeric overhangs and abnormal telomere structure in pathological shortening of telomeres, especially caused by loss-of-function telomerase mutations. Disrupted telomere structure caused by short telomeric overhangs may contribute to the mechanisms of abnormal haematopoietic compartment senescence and chromosomal instability in humanbone marrow failure.
Authors: Anna Norberg; Anna Rosén; Klas Raaschou-Jensen; Lars Kjeldsen; Jukka S Moilanen; Ylva Paulsson-Karlsson; Panagiotis Baliakas; Olli Lohi; Aymen Ahmed; Astrid O Kittang; Pär Larsson; Göran Roos; Sofie Degerman; Magnus Hultdin Journal: Eur J Hum Genet Date: 2018-02-26 Impact factor: 4.246
Authors: Taylor Wand; Mike Fang; Christina Chen; Nathan Hardy; J Philip McCoy; Bogdan Dumitriu; Neal S Young; Angélique Biancotto Journal: Cytometry A Date: 2016-09-22 Impact factor: 4.355
Authors: Judith C W Marsh; Fernanda Gutierrez-Rodrigues; James Cooper; Jie Jiang; Shreyans Gandhi; Sachiko Kajigaya; Xingmin Feng; Maria Del Pilar F Ibanez; Flávia S Donaires; João P Lopes da Silva; Zejuan Li; Soma Das; Maria Ibanez; Alexander E Smith; Nicholas Lea; Steven Best; Robin Ireland; Austin G Kulasekararaj; Donal P McLornan; Anthony Pagliuca; Isabelle Callebaut; Neal S Young; Rodrigo T Calado; Danielle M Townsley; Ghulam J Mufti Journal: Blood Adv Date: 2018-01-04
Authors: Geraldine Aubert; Gabriela M Baerlocher; Irma Vulto; Steven S Poon; Peter M Lansdorp Journal: PLoS Genet Date: 2012-05-17 Impact factor: 5.917
Authors: Christopher R Reilly; Mikko Myllymäki; Robert Redd; Shilpa Padmanaban; Druha Karunakaran; Valerie Tesmer; Frederick D Tsai; Christopher J Gibson; Huma Q Rana; Liang Zhong; Wael Saber; Stephen R Spellman; Zhen-Huan Hu; Esther H Orr; Maxine M Chen; Immaculata De Vivo; Daniel J DeAngelo; Corey Cutler; Joseph H Antin; Donna Neuberg; Judy E Garber; Jayakrishnan Nandakumar; Suneet Agarwal; R Coleman Lindsley Journal: Blood Date: 2021-09-09 Impact factor: 25.476
Authors: Yuwei Zhang; Rodrigo Calado; Mahadev Rao; Julie A Hong; Alan K Meeker; Bogdan Dumitriu; Scott Atay; Peter J McCormick; Susan H Garfield; Danny Wangsa; Hesed M Padilla-Nash; Sandra Burkett; Mary Zhang; Tricia F Kunst; Nathan R Peterson; Sichuan Xi; Suzanne Inchauste; Nasser K Altorki; Alan G Casson; David G Beer; Curtis C Harris; Thomas Ried; Neal S Young; David S Schrump Journal: PLoS One Date: 2014-07-01 Impact factor: 3.240
Authors: Mohamed Ali Mosrati; Kerstin Willander; Ingrid Jakobsen Falk; Monica Hermanson; Martin Höglund; Dick Stockelberg; Yuan Wei; Kourosh Lotfi; Peter Söderkvist Journal: Oncotarget Date: 2015-09-22